company background image
QTRX logo

Quanterix NasdaqGM:QTRX Stock Report

Last Price

US$13.41

Market Cap

US$525.0m

7D

1.4%

1Y

-47.2%

Updated

27 Aug, 2024

Data

Company Financials +

Quanterix Corporation

NasdaqGM:QTRX Stock Report

Market Cap: US$525.0m

QTRX Stock Overview

A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

About the company

QTRX fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Revenue is forecast to grow 14.65% per year

Risk Analysis

Shareholders have been diluted in the past year
Volatile share price over the past 3 months
Currently unprofitable and not forecast to become profitable over the next 3 years

Quanterix Corporation Competitors

Cryoport

NasdaqCM:CYRX

US$455.1m

OmniAb

NasdaqGM:OABI

US$517.6m

Adaptive Biotechnologies

NasdaqGS:ADPT

US$709.3m

Standard BioTools

NasdaqGM:SLGC

US$396.2m

Price History & Performance

Summary of all time highs, changes and price drops for Quanterix
Historical stock prices
Current Share PriceUS$13.41
52 Week HighUS$29.70
52 Week LowUS$10.50
Beta1.39
11 Month Change-13.82%
3 Month Change-17.12%
1 Year Change-47.18%
33 Year Change-73.73%
5 Year Change-48.18%
Change since IPO-23.24%

Recent News & Updates

Quanterix Corporation: Still Struggling To Gain Traction

Aug 26

Take Care Before Jumping Onto Quanterix Corporation (NASDAQ:QTRX) Even Though It's 26% Cheaper

Aug 15
Take Care Before Jumping Onto Quanterix Corporation (NASDAQ:QTRX) Even Though It's 26% Cheaper

Recent updates

Quanterix Corporation: Still Struggling To Gain Traction

Aug 26

Take Care Before Jumping Onto Quanterix Corporation (NASDAQ:QTRX) Even Though It's 26% Cheaper

Aug 15
Take Care Before Jumping Onto Quanterix Corporation (NASDAQ:QTRX) Even Though It's 26% Cheaper

Positive Sentiment Still Eludes Quanterix Corporation (NASDAQ:QTRX) Following 25% Share Price Slump

Jun 27
Positive Sentiment Still Eludes Quanterix Corporation (NASDAQ:QTRX) Following 25% Share Price Slump

Quanterix Corporation's (NASDAQ:QTRX) 31% Cheaper Price Remains In Tune With Revenues

Apr 14
Quanterix Corporation's (NASDAQ:QTRX) 31% Cheaper Price Remains In Tune With Revenues

Quanterix (NASDAQ:QTRX) Is In A Strong Position To Grow Its Business

Apr 05
Quanterix (NASDAQ:QTRX) Is In A Strong Position To Grow Its Business

Quanterix Corporation (NASDAQ:QTRX) Yearly Results: Here's What Analysts Are Forecasting For This Year

Mar 03
Quanterix Corporation (NASDAQ:QTRX) Yearly Results: Here's What Analysts Are Forecasting For This Year

Here's Why We're Not Too Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Situation

Oct 12
Here's Why We're Not Too Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Situation

We're Not Very Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Rate

Jun 12
We're Not Very Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Rate

We Think Quanterix (NASDAQ:QTRX) Can Afford To Drive Business Growth

Feb 10
We Think Quanterix (NASDAQ:QTRX) Can Afford To Drive Business Growth

Quanterix Corporation: Selling For Less Than Cash Value

Sep 28

We Think Quanterix (NASDAQ:QTRX) Can Afford To Drive Business Growth

Sep 23
We Think Quanterix (NASDAQ:QTRX) Can Afford To Drive Business Growth

Quanterix stock gains after insider buys reported by CEO and CFO

Aug 17

We're Hopeful That Quanterix (NASDAQ:QTRX) Will Use Its Cash Wisely

Mar 28
We're Hopeful That Quanterix (NASDAQ:QTRX) Will Use Its Cash Wisely

Is Quanterix (NASDAQ:QTRX) A Risky Investment?

Feb 21
Is Quanterix (NASDAQ:QTRX) A Risky Investment?

Shareholder Returns

QTRXUS Life SciencesUS Market
7D1.4%-0.2%0.6%
1Y-47.2%2.3%22.9%

Return vs Industry: QTRX underperformed the US Life Sciences industry which returned 3.8% over the past year.

Return vs Market: QTRX underperformed the US Market which returned 24.9% over the past year.

Price Volatility

Is QTRX's price volatile compared to industry and market?
QTRX volatility
QTRX Average Weekly Movement10.8%
Life Sciences Industry Average Movement8.8%
Market Average Movement6.3%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market3.1%

Stable Share Price: QTRX's share price has been volatile over the past 3 months.

Volatility Over Time: QTRX's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2007441Masoud Tolouewww.quanterix.com

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays.

Quanterix Corporation Fundamentals Summary

How do Quanterix's earnings and revenue compare to its market cap?
QTRX fundamental statistics
Market capUS$525.03m
Earnings (TTM)-US$39.71m
Revenue (TTM)US$129.33m

4.0x

P/S Ratio

-13.0x

P/E Ratio

Is QTRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QTRX income statement (TTM)
RevenueUS$129.33m
Cost of RevenueUS$55.06m
Gross ProfitUS$74.27m
Other ExpensesUS$113.98m
Earnings-US$39.71m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.03
Gross Margin57.42%
Net Profit Margin-30.71%
Debt/Equity Ratio0%

How did QTRX perform over the long term?

See historical performance and comparison